Furthers 10x Leadership across Genomics Applications; Brings Inventors of ATAC-seq Technology to 10x PLEASANTON, CA.—10x Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics, a pioneer in the growing epigenetics space. The acquisition will give 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in epigenomics, […]
AUCKLAND, NZ. Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year. Geneious began as a way to reduce time spent on managing and analyzing biological data and is now widely used in biotechnology and academic research. Over half a […]
Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers unparalleled depth of screening data and biological insight New platform will further enhance Horizon’s CRISPR screening capabilities Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company”, or […]
On August 24, 2018, the 6th meeting of the China-Thailand Joint Commission on trade investment, and economic cooperation took place in Bangkok, Thailand. During the conference, BGI’s cooperation with the Chulabhorn Royal Academy and Eastern Economic Corridor (EEC) office of Thailand was officially announced. Dr. Somkid Jatusripitak, Deputy Prime Minister of Thailand; Dr. Uttama Savanayana, […]
Facility Will Enhance Enzo’s Ability to Produce and Distribute Its Growing Portfolio of Molecular Assays, Immunohistochemistry, Immunoassays and Immuno-oncology Products and Services Anticipates Significant Tax and Other Incentives for Enzo’s Entire Farmingdale New York Campus NEW YORK, NY – Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of […]
Enabling Growing Genomic Applications in Chinese Clinical Market SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing Systemreceived the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals […]
Thermo Scientific FAIMS Pro device delivers selectivity and productivity in high-resolution mass spectrometry FLORENCE, Italy — IMSC 2018 – Proteomic scientists can now take advantage of a next-generation differential ion mobility device that seamlessly integrates with high-resolution mass spectrometers to provide workflow efficiency and data quality for experiments ranging from the discovery of disease biomarkers to the identification of […]
PORTLAND, OR – August 22, 2018 – MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid immunotherapy drug development programs for the pharmaceutical industry. The latest approach in the evolving field of immuno-oncology, tumor mutation burden (TMB) analysis is rapidly becoming an independent predictor […]
Two innovative companies with unique technologies unite, creating powerful tools for researches and companies developing the treatments of tomorrow. During recent years, 3D-Bioprinting has emerged as a powerful cell culture technology but has also been hampered by the lack of a biologically relevant Bioink. Today, CELLINK launches a brand new Bioink containing BIOLAMININS, that will […]
Eppendorf is a renowned innovator in the field of PCR Instruments and consumables with roughly 30 years of experience in developing and producing PCR equipment. Now Eppendorf extends its range of PCR accessories with a new software application to control up to fifty Mastercycler X50 eco modules remotely. The CycleManager X50 support the PCR workflow […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
